- Home
- PCVX vs KFY Comparison
PCVX vs KFY Comparison
Compare PCVX & KFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCVX | KFY |
|---|---|---|
| Founded | 2013 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 3.4B |
| IPO Year | 2020 | 1999 |
Fundamental Metrics
Financial Performance| Metric | PCVX | KFY |
|---|---|---|
| Price | $46.57 | $66.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $101.67 | $78.00 |
| AVG Volume (30 Days) | ★ 1.5M | 356.2K |
| Earning Date | 11-04-2025 | 12-09-2025 |
| Dividend Yield | N/A | ★ 2.91% |
| EPS Growth | N/A | ★ 33.45 |
| EPS | N/A | ★ 4.69 |
| Revenue | N/A | ★ $2,763,755,000.00 |
| Revenue This Year | N/A | $4.54 |
| Revenue Next Year | N/A | $4.41 |
| P/E Ratio | ★ N/A | $14.10 |
| Revenue Growth | N/A | ★ 0.93 |
| 52 Week Low | $27.66 | $59.23 |
| 52 Week High | $94.60 | $78.50 |
Technical Indicators
Market Signals| Indicator | PCVX | KFY |
|---|---|---|
| Relative Strength Index (RSI) | 51.97 | 50.74 |
| Support Level | $43.78 | $65.17 |
| Resistance Level | $48.11 | $67.25 |
| Average True Range (ATR) | 1.99 | 1.34 |
| MACD | -0.49 | 0.40 |
| Stochastic Oscillator | 42.99 | 75.51 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About KFY Korn Ferry
Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.